Collegium Pharmaceutical (COLL) Assets Average (2016 - 2025)
Collegium Pharmaceutical (COLL) has 10 years of Assets Average data on record, last reported at $1.6 billion in Q3 2025.
- For Q3 2025, Assets Average rose 19.02% year-over-year to $1.6 billion; the TTM value through Sep 2025 reached $1.6 billion, up 19.02%, while the annual FY2024 figure was $1.4 billion, 21.12% up from the prior year.
- Assets Average reached $1.6 billion in Q3 2025 per COLL's latest filing, down from $1.6 billion in the prior quarter.
- Across five years, Assets Average topped out at $1.6 billion in Q4 2024 and bottomed at $645.0 million in Q1 2021.
- Average Assets Average over 5 years is $1.2 billion, with a median of $1.2 billion recorded in 2023.
- Peak YoY movement for Assets Average: surged 83.24% in 2022, then dropped 10.73% in 2024.
- A 5-year view of Assets Average shows it stood at $716.9 million in 2021, then surged by 65.64% to $1.2 billion in 2022, then decreased by 2.28% to $1.2 billion in 2023, then skyrocketed by 42.13% to $1.6 billion in 2024, then fell by 2.99% to $1.6 billion in 2025.
- Per Business Quant database, its latest 3 readings for Assets Average were $1.6 billion in Q3 2025, $1.6 billion in Q2 2025, and $1.6 billion in Q1 2025.